Drug Shortage Report for VEPESID

Last updated on 2019-07-05 History
Report ID 70228
Drug Identification Number 00616192
Brand name VEPESID
Common or Proper name Etoposide
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH
Market Status MARKETED
Active Ingredient(s) ETOPOSIDE
Strength(s) 50MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 1 BTL x 20
ATC code L01CB
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-07-01
Actual start date
Estimated end date 2019-07-01
Actual end date 2019-07-01
Shortage status Resolved
Updated date 2019-07-05
Company comments Stock is being allocated. Generics on back order for Etoposide IV has increased demand for Vepesid capsules.
Health Canada comments
Contact Address ZIEGELHOF 24
GREIFSWALD, MECKLENBURG-VORPOMMERN
GERMANY 17489
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2019-07-05 French Compare
v20 2019-07-05 English Compare
v19 2019-07-02 English Compare
v18 2019-04-18 French Compare
v17 2019-04-18 English Compare
v16 2019-03-04 French Compare
v15 2019-03-04 English Compare
v14 2019-03-04 French Compare
v13 2019-03-04 English Compare
v12 2019-03-04 French Compare
v11 2019-03-04 English Compare
v10 2019-03-04 French Compare
v9 2019-03-04 English Compare
v8 2019-02-13 French Compare
v7 2019-02-13 English Compare
v6 2019-01-22 French Compare
v5 2019-01-22 English Compare
v4 2019-01-22 French Compare
v3 2019-01-22 English Compare
v2 2018-12-20 French Compare

Showing 1 to 20 of 21